98
01/04/2024
31/03/2025
2025-03-31
false
false
false
false
false
false
false
true
false
false
true
false
false
false
false
false
false
false
2024-04-01
Sage Accounts Production 23.0 - FRS102_2023
xbrli:pure
xbrli:shares
iso4217:GBP
09989015
2024-04-01
2025-03-31
09989015
2025-03-31
09989015
2024-03-31
09989015
2023-04-01
2024-03-31
09989015
2024-03-31
09989015
2023-03-31
09989015
bus:RegisteredOffice
2024-04-01
2025-03-31
09989015
bus:OrdinaryShareClass1
2024-04-01
2025-03-31
09989015
bus:OrdinaryShareClass2
2024-04-01
2025-03-31
09989015
bus:OrdinaryShareClass3
2024-04-01
2025-03-31
09989015
bus:LeadAgentIfApplicable
2024-04-01
2025-03-31
09989015
bus:Director1
2024-04-01
2025-03-31
09989015
bus:Director2
2024-04-01
2025-03-31
09989015
bus:Director3
2024-04-01
2025-03-31
09989015
bus:Director4
2024-04-01
2025-03-31
09989015
bus:Director5
2024-04-01
2025-03-31
09989015
core:PlantMachinery
2024-03-31
09989015
core:FurnitureFittingsToolsEquipment
2024-03-31
09989015
core:PlantMachinery
2025-03-31
09989015
core:FurnitureFittingsToolsEquipment
2025-03-31
09989015
core:WithinOneYear
2025-03-31
09989015
core:WithinOneYear
2024-03-31
09989015
core:ShareCapital
2025-03-31
09989015
core:ShareCapital
2024-03-31
09989015
core:RetainedEarningsAccumulatedLosses
2025-03-31
09989015
core:RetainedEarningsAccumulatedLosses
2024-03-31
09989015
bus:OrdinaryShareClass1
core:ShareCapital
2025-03-31
09989015
bus:OrdinaryShareClass1
core:ShareCapital
2024-03-31
09989015
bus:OrdinaryShareClass2
core:ShareCapital
2025-03-31
09989015
bus:OrdinaryShareClass2
core:ShareCapital
2024-03-31
09989015
bus:OrdinaryShareClass3
core:ShareCapital
2025-03-31
09989015
bus:OrdinaryShareClass3
core:ShareCapital
2024-03-31
09989015
core:PlantMachinery
2024-04-01
2025-03-31
09989015
core:FurnitureFittingsToolsEquipment
2024-04-01
2025-03-31
09989015
core:PlantMachinery
2024-03-31
09989015
core:FurnitureFittingsToolsEquipment
2024-03-31
09989015
bus:SmallEntities
2024-04-01
2025-03-31
09989015
bus:AuditExempt-NoAccountantsReport
2024-04-01
2025-03-31
09989015
bus:SmallCompaniesRegimeForAccounts
2024-04-01
2025-03-31
09989015
bus:PrivateLimitedCompanyLtd
2024-04-01
2025-03-31
09989015
bus:FullAccounts
2024-04-01
2025-03-31
09989015
core:ComputerEquipment
2025-03-31
09989015
core:ComputerEquipment
2024-03-31
09989015
core:ComputerEquipment
2024-04-01
2025-03-31
09989015
core:AllAssociates
2024-04-01
2025-03-31
Company registration number:
09989015
Southport & Formby Health Limited
Unaudited filleted financial statements
31 March 2025
Southport & Formby Health Limited
Contents
Directors and other information
Statement of financial position
Notes to the financial statements
Southport & Formby Health Limited
Directors and other information
|
|
|
|
|
Directors |
Mr Paul Ashby |
(Resigned 4 November 2024) |
|
|
Ms Jane Ayres |
|
|
|
Ms Nicole Marshall |
|
|
|
Dr Lindsay McClelland |
|
|
|
Dr Abdul Zubairu |
|
|
|
|
|
|
|
|
|
|
Company number |
09989015 |
|
|
|
|
|
|
|
|
|
|
Registered office |
3 Wight Moss Way |
|
|
|
Southport |
|
|
|
PR8 4HQ |
|
|
|
|
|
|
|
|
|
|
Business address |
3 Wight Moss Way |
|
|
|
Southport |
|
|
|
PR8 4HQ |
|
|
|
|
|
|
|
|
|
|
Accountants |
Forshaws Accountants Limited |
|
|
|
Crossens Way Business Park |
|
|
|
Crossens Way |
|
|
|
Southport |
|
|
|
PR9 9LY |
|
|
|
|
|
Southport & Formby Health Limited
Statement of financial position
31 March 2025
|
|
|
2025 |
|
|
|
2024 |
|
|
|
|
Note |
£ |
|
£ |
|
£ |
|
£ |
|
|
|
|
|
|
|
|
|
|
|
Fixed assets |
|
|
|
|
|
|
|
|
|
|
Tangible assets |
|
5 |
48,832 |
|
|
|
67,434 |
|
|
|
|
|
_______ |
|
|
|
_______ |
|
|
|
|
|
|
|
48,832 |
|
|
|
67,434 |
|
|
|
|
|
|
|
|
|
|
|
Current assets |
|
|
|
|
|
|
|
|
|
|
Stocks |
|
|
- |
|
|
|
970 |
|
|
|
Debtors |
|
6 |
321,993 |
|
|
|
649,886 |
|
|
|
Cash at bank and in hand |
|
|
1,118,825 |
|
|
|
890,020 |
|
|
|
|
|
_______ |
|
|
|
_______ |
|
|
|
|
|
1,440,818 |
|
|
|
1,540,876 |
|
|
|
Creditors: amounts falling due |
|
|
|
|
|
|
|
|
|
|
within one year |
|
7 |
(
578,191) |
|
|
|
(
574,935) |
|
|
|
|
|
_______ |
|
|
|
_______ |
|
|
|
Net current assets |
|
|
|
|
862,627 |
|
|
|
965,941 |
|
|
|
|
|
_______ |
|
|
|
_______ |
|
Total assets less current liabilities |
|
|
|
|
911,459 |
|
|
|
1,033,375 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provisions for liabilities |
|
|
|
|
(
12,208) |
|
|
|
(
16,859) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
_______ |
|
|
|
_______ |
|
Net assets |
|
|
|
|
899,251 |
|
|
|
1,016,516 |
|
|
|
|
|
_______ |
|
|
|
_______ |
|
|
|
|
|
|
|
|
|
|
|
Capital and reserves |
|
|
|
|
|
|
|
|
|
|
Called up share capital |
|
8 |
|
|
24 |
|
|
|
24 |
|
Profit and loss account |
|
|
|
|
899,227 |
|
|
|
1,016,492 |
|
|
|
|
|
_______ |
|
|
|
_______ |
|
Shareholders funds |
|
|
|
|
899,251 |
|
|
|
1,016,516 |
|
|
|
|
|
_______ |
|
|
|
_______ |
|
|
|
|
|
|
|
|
|
|
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsibilities:
-
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
-
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
These financial statements were approved by the
board of directors
and authorised for issue on
03 October 2025
, and are signed on behalf of the board by:
Dr Lindsay McClelland
Director
Company registration number:
09989015
Southport & Formby Health Limited
Notes to the financial statements
Year ended 31 March 2025
1.
General information
The principal activity of the company is that of providing general medical services.
2.
Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3.
Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Going concern
The directors believe that the company is experiencing good levels of sales growth and profitability, and that it is well placed to manage its business risks successfully. Accordingly they have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the financial statements.
Turnover
Turnover is measured at the fair value of the consideration received or receivable for services rendered, net of discounts and Value Added Tax.Revenue from the rendering of services is measured by reference to the stage of completion of the service transaction at the end of the reporting period provided that the outcome can be reliably estimated. When the outcome cannot be reliably estimated, revenue is recognised only to the extent that expenses recognised are recoverable.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively.Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Tangible assets
tangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in capital and reserves, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
|
|
|
|
|
Medical equipment |
- |
25% Straight line
|
|
Fittings fixtures and equipment |
- |
25% Straight line
|
|
Computer equipment |
- |
25% Straight line
|
|
|
|
|
If there is an indication that there has been a significant change in depreciation rate, useful life or residual value of tangible assets, the depreciation is revised prospectively to reflect the new estimates.
Impairment
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. When it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stocks to their present location and condition.
Provisions
Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event; it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense.
Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised in finance costs in profit or loss in the period it arises.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument.
Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.
Debt instruments are subsequently measured at amortised cost.
4.
Employee numbers
The average number of persons employed by the company during the year amounted to
98
(2024:
75
).
5.
Tangible assets
|
|
Plant and machinery |
Fixtures, fittings and equipment |
Tangible assets - user defined |
Total |
|
|
|
|
|
£ |
£ |
£ |
£ |
|
|
|
|
Cost |
|
|
|
|
|
|
|
|
At 1 April 2024 and 31 March 2025 |
26,858 |
47,818 |
51,538 |
126,214 |
|
|
|
|
|
_______ |
_______ |
_______ |
_______ |
|
|
|
|
Depreciation |
|
|
|
|
|
|
|
|
At 1 April 2024 |
26,682 |
12,142 |
19,806 |
58,630 |
|
|
|
|
Charge for the year |
176 |
10,387 |
8,189 |
18,752 |
|
|
|
|
|
_______ |
_______ |
_______ |
_______ |
|
|
|
|
At 31 March 2025 |
26,858 |
22,529 |
27,995 |
77,382 |
|
|
|
|
|
_______ |
_______ |
_______ |
_______ |
|
|
|
|
Carrying amount |
|
|
|
|
|
|
|
|
At 31 March 2025 |
- |
25,289 |
23,543 |
48,832 |
|
|
|
|
|
_______ |
_______ |
_______ |
_______ |
|
|
|
|
At 31 March 2024 |
176 |
35,676 |
31,732 |
67,584
|
|
|
|
|
|
_______ |
_______ |
_______ |
_______ |
|
|
|
|
|
|
|
|
|
|
|
|
6.
Debtors
|
|
|
2025 |
2024 |
|
|
|
£ |
£ |
|
Trade debtors |
|
217,817 |
351,752 |
|
Other debtors |
|
104,176 |
298,134 |
|
|
|
_______ |
_______ |
|
|
|
321,993 |
649,886 |
|
|
|
_______ |
_______ |
|
|
|
|
|
7.
Creditors: amounts falling due within one year
|
|
|
2025 |
2024 |
|
|
|
£ |
£ |
|
Trade creditors |
|
21,909 |
151,760 |
|
Corporation tax |
|
129,309 |
117,739 |
|
Social security and other taxes |
|
45,646 |
43,635 |
|
Other creditors |
|
381,327 |
261,801 |
|
|
|
_______ |
_______ |
|
|
|
578,191 |
574,935 |
|
|
|
_______ |
_______ |
|
|
|
|
|
8.
Called up share capital
Issued, called up and fully paid
|
|
|
2025 |
|
|
|
2024 |
|
|
|
|
|
No |
|
£ |
|
No |
|
£ |
|
Ordinary A shares of £
0.01 each |
|
991 |
|
10 |
|
984 |
|
10 |
|
Ordinary B shares of £
1.00 each |
|
11 |
|
11 |
|
11 |
|
11 |
|
Ordinary C shares of £
1.00 each |
|
3 |
|
3 |
|
3 |
|
3 |
|
|
|
_______ |
|
_______ |
|
_______ |
|
_______ |
|
|
|
1,005 |
|
24 |
|
998 |
|
24 |
|
|
|
_______ |
|
_______ |
|
_______ |
|
_______ |
|
|
|
|
|
|
|
|
|
|
9.
Related party transactions
As detailed in Note 7 and Note 8, at the current and prior year balance sheet date, there was amounts outstanding to/from Southport and Formby PCN, a connected party. Transactions with Southport and Formby PCN took place in the year of which its member practices are shareholders in the Company. Transactions took place under normal market conditions.
10.
Controlling party
The company is not under the control of any one individual.